GH Research Stock (NASDAQ: GHRS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 128.722K |
Day Range | - - - |
52 Wk Range | 5.050 - 14.640 |
Market Cap | $562.024M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 8.85% |
Days to Cover | 7.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GH Research (NASDAQ: GHRS) through any online brokerage.
Other companies in GH Research’s space includes: Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), SNDL (NASDAQ:SNDL), WAVE Life Sciences (NASDAQ:WVE) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for GH Research (NASDAQ: GHRS) was reported by HC Wainwright & Co. on Monday, March 4, 2024. The analyst firm set a price target for 40.00 expecting GHRS to rise to within 12 months (a possible 270.29% upside). 7 analyst firms have reported ratings in the last year.
The stock price for GH Research (NASDAQ: GHRS) is $10.8023 last updated April 3, 2024 at 4:02 PM EDT.
There are no upcoming dividends for GH Research.
GH Research’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for GH Research.
GH Research is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.